| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| R&D Expense | $21.3M | -12.7% |
| SG&A Expense | $10.8M | -13.8% |
| Pre-tax Income | -$26.6M | +24.5% |
| Income Tax | $2K | +101.4% |
| Net Income | -$26.6M | +24.3% |
| EPS (Basic) | -$0.60 | +25.0% |
| EPS (Diluted) | -$0.60 | +25.0% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $33.7M | -41.0% |
| Short-term Investments | $114.4M | +3.8% |
| Accounts Receivable | $135K | +2074.5% |
| Current Assets | $148.8M | -12.0% |
| Total Assets | $149.1M | -12.0% |
| Current Liabilities | $3.5M | +51.3% |
| Total Liabilities | $3.5M | +46.4% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.8M | +31.1% |
| Investing Cash Flow | -$3.5M | +93.3% |
| Financing Cash Flow | -$68K | -127.0% |
| Stockholders' Equity |
| $145.6M |
| -12.9% |